First Claim

obtaining, for a subject, a mean glucose value information, a glycemic risk weight, and a HbA1C level of the subject;

determining, using the one or more processors, a rate of glycation of the subject based on a ratio of the mean glucose value information of the subject and the HbA1C level of the subject;

determining, using the one or more processors, a target HbA1C level for the subject based at least in part on two or more subject-specific weights including at least the rate of glycation of the subject and the glycemic risk weight;

providing, using the one or more processors, a therapy recommendation including a dosage for an insulin bolus on a display device operatively coupled to the one or more processors based at least in part on the determined target HbA1C level of the subject; and

administering the insulin bolus to the subject using an infusion device according to the therapy recommendation.

1 Assignment

0 Petitions

Accused Products

Abstract

Methods to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided. Systems to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided. Kits to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided.

Method to determine the degree and stability of blood glucose control in patients with diabetes mellitus via the creation and continuous update of new statistical indicators in blood glucose monitors or free standing computers

System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device